Is it benzo withdrawal, or is the anxiety coming back?
A person a few weeks into a benzodiazepine taper cuts the dose, and within days the anxiety is back, worse than before. Is this withdrawal, or is the original condition returning now that the drug no longer holds it down? Often it is withdrawal, sometimes it is both, and there are ways to tell them apart.
The two overlap. Anxiety, insomnia, muscle tension, a racing heart, and poor concentration appear on both lists, so what people call an anxiety return of symptoms, meaning the return of the anxiety they had before the drug, can look much like a withdrawal reaction. A less knowledgeable doctor sees the overlap and treats it as the old anxiety returning.
A person who took a benzodiazepine as prescribed and now feels worse each time the dose falls has physical dependence, the nervous system’s adaptation to a drug it has come to expect. Chapter I of the Ashton Manual, written by Professor C. Heather Ashton, says this dependence “can develop within a few weeks or months of regular or repeated use,” and the 2020 update to the United States Food and Drug Administration (FDA) boxed warning puts it at “several days to weeks, even as prescribed.”
Dependence is not addiction, and the symptoms after a dose cut are a nervous system readjusting. So, how does withdrawal give itself away?
Withdrawal follows the dose cut. Returning anxiety follows your life.
Timing is the first clue. Withdrawal is tied to the calendar of reductions: a cut is made, and the symptoms follow within a predictable window. Anxiety returning on its own follows the circumstances that produced it, a job, a loss, a season, and it does not care when the last tablet was reduced.
How soon after a cut depends on the drug. Table 1 in Chapter I of the Manual gives alprazolam (Xanax) a half-life of 6 to 12 hours, lorazepam (Ativan) 10 to 20 hours, temazepam (Restoril) 8 to 22 hours, clonazepam (Klonopin) 18 to 50 hours, and diazepam (Valium) 20 to 100 hours, with an active metabolite that lasts 36 to 200 hours. On those figures temazepam belongs with the short-acting drugs.
A drug is mostly gone after about five half-lives, which is this site’s arithmetic rather than the Manual’s. So, a person cutting a short-acting drug can feel it within a day or two, while a person cutting diazepam may feel nothing for a week. Like a bruise that shows up the day after the knock, withdrawal from a long-acting drug lags the cut that caused it.
Withdrawal brings symptoms the person never had before.
The second clue is the character of the symptoms. Chapter III of the Manual grants that many withdrawal symptoms are the same as those of anxiety, then says that “certain symptom clusters are particularly characteristic of benzodiazepine withdrawal.” Professor Ashton lists hypersensitivity to sound, light, touch, taste, and smell, and perceptual distortions such as a floor that seems to undulate, walls that seem to tilt, and the sensation of walking on cotton wool.
The same passage adds that depersonalization, feelings of unreality, and tingling and numbness are more common than in anxiety states, and that visual hallucinations, distortion of the body image, feelings of insects crawling on the skin, muscle twitching, and weight loss are “not uncommon in benzodiazepine withdrawal but unusual in anxiety states.” That is the Manual’s own dividing line.
Did you have this symptom before you ever took a benzodiazepine? Returning anxiety usually looks like the anxiety a person already knew, and burning skin, a tilting floor, and a head that feels like a balloon are not old acquaintances.
Akathisia, an inner restlessness that forces a person to keep moving, is so often mistaken for anxiety that it gets treated with more of the drug that caused it. Ashton Manual Guide covers it in its article on akathisia in benzo withdrawal.
Withdrawal comes in waves. Returning anxiety keeps a steadier level.
The third clue is the shape over time. In Chapter III, under “Course of withdrawal,” the Manual says symptoms “characteristically wax and wane, varying in severity and type from day to day, week to week, and even during the course of a day,” and that “windows” of feeling well appear after some weeks and gradually grow longer. This site explains the pattern, known as windows and waves, in its article on why symptoms fluctuate.
Anxiety returning on its own tends to hold a steadier level from one day to the next, and it does not usually vanish for an afternoon and come back the next morning with a new companion. While anxiety has bad days too, a symptom that changes its type as well as its intensity is behaving like withdrawal.
The old coping tools work on anxiety and mostly miss withdrawal.
The fourth clue is the response to what used to help. Slow breathing, muscle relaxation, and the thought work learned in therapy usually take the edge off returning anxiety. They rarely touch a burning skin sensation, a tilting floor, or a jolt of electricity in the head. If a tool that reliably worked for years now does nothing at all, that is information about what the symptom is.
How do you sort this out in practice?
By writing things down, in seven steps. First, keep a symptom journal with the time, an intensity from 1 to 10, and a few words on each symptom, noting whether it comes in waves, sits at a constant level, or follows a pattern through the day. Second, record every dose reduction on the same page, so a symptom’s timing against the last cut is there to see.
Third, mark anything you have never felt before, since muscle twitches, tingling, sensitivity to light or sound, and perceptual oddities are the symptoms the Manual singles out as characteristic of withdrawal. Fourth, when a symptom is at its height, try the coping tool that used to work and write down what happened. Fifth, note the objective signs you can measure, such as pulse, tremor, and sweating.
Sixth, look at the trend over weeks rather than days: withdrawal after a cut tends to peak and then ease, sometimes unevenly, while returning anxiety tends to hold its level or follow its circumstances. Seventh, bring the record to the prescriber, because the judgment rests on pattern, timing, and history, and no test makes it for them.
A dose is not a diagnostic test.
The tempting shortcut goes like this: take a dose, and if it helps, the symptoms were withdrawal. The test answers nothing, because a benzodiazepine relieves returning anxiety just as readily as it relieves withdrawal, so all it proves is that the drug still works.
It is also a change to the taper that nobody planned. Chapter II of the Manual says, “As far as possible, never go backwards,” while allowing a person to “stand still at a certain stage” of the schedule for a few weeks if circumstances change, and in this site’s view a small increase agreed with your prescriber can also be reasonable, decided case by case.
Ashton Manual Guide’s position follows from that: when a person cannot tell whether a symptom is withdrawal or anxiety, hold the current dose rather than cut, and take the record to the prescriber. A hold is not failure.
The pace of the taper decides how much of this you see.
Most of this confusion arises when a taper runs faster than a nervous system can follow. The Manual’s pace, in Chapter II, is unhurried: “There is no need to hurry withdrawal,” reductions of “up to one tenth at each decrement,” each step held for a week or two, and the steps growing smaller as the dose falls. It is a shape, and the rate, the Manual says, is an individual matter.
Many prescribers now take that shape further with hyperbolic tapering, in which every reduction is sized to the dose that remains. The Maudsley Deprescribing Guidelines describe this approach. It is not something Professor Ashton wrote, but it follows her own instruction that the steps grow smaller as the dose falls. The benzodiazepine taper calculator on this site shows a schedule of that shape, as an educational planning tool, with the pace set with the prescriber.
Pace is not only about comfort. Chapter III of the Manual notes that rapid withdrawal can precipitate fits as a rebound reaction, and that this is extremely rare with slow tapering. The 2020 FDA warning says the same: stopping abruptly or reducing the dose too quickly can cause withdrawal reactions, including seizures, which can be life-threatening. A seizure is a reason to call 911 or the local emergency number, and so is any other medical emergency.
Despair belongs here too, because people in withdrawal feel it and rarely say so. Anyone having thoughts of suicide can call or text the 988 Suicide and Crisis Lifeline at any hour, and a wave that brings those thoughts is one to tell the prescriber about rather than ride out alone.
Questions readers ask about withdrawal and returning anxiety.
Can withdrawal and returning anxiety happen at the same time?
Yes, and in the middle of a taper it is common, because the drug is no longer fully covering the original anxiety while the reductions are producing withdrawal of their own.
How long does withdrawal last compared with returning anxiety?
Withdrawal after a single cut usually peaks and then eases over days to weeks, and the Manual says that with slow tapering most people are clear within a few months of the last tablet, while a minority carry protracted symptoms that recede over a year and sometimes longer. Returning anxiety does not follow a taper’s timetable. It holds its level or follows its circumstances.
Will taking a dose tell me whether it is withdrawal or returning anxiety?
No. A benzodiazepine relieves both, so a dose that helps proves only that the drug still works, and a dose taken on your own as a test is a change to the taper that nobody planned. Any increase is a decision for you and your prescriber, not a test to run alone.
Are there medical tests that can tell withdrawal from returning anxiety?
No. There is no laboratory test or scan for either, and a doctor’s tests are for ruling out conditions that imitate both, such as thyroid disease or a vitamin deficiency.
If I am not sure which one it is, should I slow my taper?
Yes. Holding at the current dose for a few weeks while the picture clears is consistent with the Manual’s advice that there is no need to hurry, and any change of pace is a decision to make with the prescriber rather than alone.
The two conditions can look alike for a day or two. Watch the calendar, watch for the symptoms that are new, watch the waves, and hold when the picture is unclear, and the difference usually shows itself.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.
